Orchestra BioMed Holdings (OBIO) Return on Sales (2022 - 2026)
Orchestra BioMed Holdings' (OBIO) quarterly Return on Sales came in at 2.25% in Q1 2026, down 203.0% year-on-year from 2.18% in Q1 2025, and down 108933.57% on a QoQ basis from 0.0% in Q4 2025.
Orchestra BioMed Holdings (OBIO) Return on Sales (2022 - 2026) Analysis & Trends
Orchestra BioMed Holdings (OBIO) has 5 years of Return on Sales data on file, last reported at 2.25% in Q1 2026.
- On a quarterly basis, Return on Sales fell 203.0% year-over-year to 2.25% in Q1 2026; TTM through Mar 2026 was 0.02%, a 25.0% increase from a year earlier, with the FY2025 full-year figure at 0.05%, up 55.0% from the prior year.
- Return on Sales for Q1 2026 stood at 2.25%, down from 0.0% in the prior quarter.
- Over the last five years, Return on Sales for OBIO reached as high as 0.0% in Q4 2025 and fell as low as 2.25% in Q1 2026.
- Historically, Return on Sales has averaged 0.36% across 5 years, with a median of 0.22% in 2025.
- Across the five-year window, Return on Sales jumped 64 bps in 2025 and slumped 203 bps in 2026, its largest moves.
- Year by year, Return on Sales stood at 0.09% in 2022, then sank by 406 bps to 0.47% in 2023, then plunged by 37 bps to 0.64% in 2024, then jumped by 100 bps to 0.0% in 2025, then tumbled by 108934 bps to 2.25% in 2026.
- Per Business Quant data, the three most recent Return on Sales figures were 2.25% in Q1 2026, 0.0% in Q4 2025, and 0.24% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.00% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 0.00% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.00% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 0.00% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Orchestra BioMed Holdings | 228.31 Mn | 143.68 Mn | 78,000.00 | -2.25% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.25% |
| Dec 31, 2025 | 0.00% |
| Sep 30, 2025 | -0.24% |
| Jun 30, 2025 | -0.26% |
| Mar 31, 2025 | -0.22% |
| Dec 31, 2024 | -0.64% |
| Sep 30, 2024 | -0.18% |
| Jun 30, 2024 | -0.32% |
| Mar 31, 2024 | -0.25% |
| Dec 31, 2023 | -0.47% |
| Sep 30, 2023 | -0.53% |
| Jun 30, 2023 | -0.19% |
| Mar 31, 2023 | -0.10% |
| Dec 31, 2022 | -0.09% |
| Sep 30, 2022 | -0.09% |
| Jun 30, 2022 | -0.20% |
| Mar 31, 2022 | -0.06% |